Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
PharmTech
12m
FDA Approves RSV Vaccine
Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...
Zacks.com on MSN
42m
PFE Gets FDA Nod for Expanded Use of RSV Vaccine Abrysvo
The FDA approves Pfizer's RSV vaccine, Abrysvo, for adults aged 18-59 years with increased risk of the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
NK troops in RU confirmed
Linked to E. coli outbreak
Trespassing charge upheld
Arlington visit records order
Veteran film producer dies
MO court upholds release
2 US troops injured in raid
Dodgers legend dies
Gun assault trial delayed
Giant ‘ghost’ fish spotted
Lake Erie toxic algae study
First father-son duo in NBA
Hashem Safieddine killed
Apple, Goldman Sachs fined
Funds corruption guilty plea
DOJ alleges racial bias
To close 150 locations
GA election rules appeal
US fines American Airlines
FDA approves RSV vaccine
Bird flu infects 4 in WA
G7 Ukraine loan advances
To appear on Rogan podcast
FAA finalizes safety rules
Brain stimulation study
Six indicted for fraud in Ohio
Hospitals' IV fluid shortage
Related topics
Food and Drug Administration
Abrysvo
Feedback